Kanya Taku, Ponnaiah Sivayadevi, Palanivel Nirmaladevi, Babu Adalabbai Nagoor Meeran Mohamed Meethen Maalik, Somasundaram Gayathri Devi
Department of Dermatology, Venereology and Leprosy, Tirunelveli Medical College and Hospital, Tamil Nadu, India.
Indian Dermatol Online J. 2025 Sep 1;16(5):732-736. doi: 10.4103/idoj.idoj_792_24. Epub 2025 Aug 19.
Keloids are benign overgrowth of fibrous tissue extending beyond the original wound margin. The management of keloids remains challenging despite the various treatments available. Studies have shown that combination therapies are superior to monotherapy.
To compare the effectiveness of intralesional triamcinolone acetonide with fractional CO2 laser against intralesional triamcinolone acetonide with intralesional verapamil in treating keloids.
This study included 24 patients with single or multiple keloids. After obtaining consent, 12 patients each were allocated to either fractional CO2 with intralesional triamcinolone group (Group 1) or intralesional verapamil with intralesional triamcinolone group (Group 2). Keloid scars were assessed and scored according to the Vancouver scar scale (VSS) during each visit with serial photographs. The procedures were repeated at an interval of four weeks for a total of four sittings and participants were followed up for another six months.
Both groups showed significant improvement in the clinical appearance of keloids. The overall response was better in Group 2. In VSS assessment, there was a faster and better rate of reduction in height with Group 2. Pliability and vascularity improved significantly and none had recurrences of keloid till the end of the study in both groups.
Limitations of the study are the small sample size and short duration of follow-up.
Both the combination groups are safe and efficacious methods to treat keloid. Intralesional verapamil with triamcinolone showed better and faster clinical improvement compared to fractional CO2 laser with intralesional triamcinolone.
瘢痕疙瘩是纤维组织的良性过度生长,超出了原始伤口边缘。尽管有多种治疗方法,但瘢痕疙瘩的治疗仍然具有挑战性。研究表明,联合治疗优于单一疗法。
比较曲安奈德皮损内注射联合二氧化碳点阵激光与曲安奈德皮损内注射联合维拉帕米皮损内注射治疗瘢痕疙瘩的疗效。
本研究纳入24例单发或多发瘢痕疙瘩患者。获得同意后,将12例患者分为二氧化碳点阵激光联合曲安奈德皮损内注射组(第1组)和维拉帕米皮损内注射联合曲安奈德皮损内注射组(第2组)。每次就诊时根据温哥华瘢痕量表(VSS)对瘢痕疙瘩进行评估和评分,并拍摄系列照片。每四周重复一次治疗,共进行四次,对参与者随访另外六个月。
两组瘢痕疙瘩的临床表现均有显著改善。第2组的总体反应更好。在VSS评估中,第2组瘢痕高度降低的速度更快、效果更好。两组的柔韧性和血管分布均有显著改善,直至研究结束均无瘢痕疙瘩复发。
本研究的局限性在于样本量小和随访时间短。
两种联合治疗方法都是治疗瘢痕疙瘩的安全有效的方法。与二氧化碳点阵激光联合曲安奈德皮损内注射相比,维拉帕米皮损内注射联合曲安奈德显示出更好、更快的临床改善效果。